PharmiWeb.com - Global Pharma News & Resources
01-Apr-2019

Dr. Sarah Fakih joins MorphoSys as Head of Corporate Communications and Investor Relations (news with additional features)

DGAP-News: MorphoSys AG / Key word(s): Personnel


The issuer is solely responsible for the content of this announcement.



Additional features:

Document: http://n.eqs.com/c/fncls.ssp?u=KXYOSTNUSA
Document title: Media Release


01.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: MorphoSys AG
Semmelweisstr. 7
82152 Planegg
Germany
Phone: +49 (0)89 899 27-0
Fax: +49 (0)89 899 27-222
E-mail: investors@morphosys.com
Internet: www.morphosys.com
ISIN: DE0006632003
WKN: 663200
Indices: MDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 794239

 
End of News DGAP News Service

Editor Details

Last Updated: 01-Apr-2019